CLEARSIDE BIOMEDICAL
1.1100
07-十一月-24 15:59:58
15 分钟延时
股票
+0.0300
+2.78%
今日范围
1.0800 - 1.1300
ISIN
N/A
来源
NASDAQ
-
02 4月 2024 07:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 3月 2024 07:05:00 条件 Nasdaq GlobeNewswire
-
12 3月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
12 3月 2024 09:45:16 条件 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
11 3月 2024 12:16:48 条件 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
08 3月 2024 09:45:23 条件 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
07 3月 2024 09:45:03 条件 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
06 3月 2024 12:23:17 条件 NetDania Notify
-
29 2月 2024 07:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
14 12月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
08 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
07 11月 2023 16:20:00 条件 Nasdaq GlobeNewswire
-
02 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
01 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
31 10月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
16 10月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit
03 10月 2023 16:35:00 条件 Nasdaq GlobeNewswire